The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain
Open accessAbstract
Chronic inflammation is known to play an important role in the heterogeneous pathogenesis of Alzheimer's disease (AD). Activated astrocytes expressing glial fibrillary acidic protein (GFAP) are closely associated with AD pathology, such as tangles, neuritic plaques and amyloid depositions. Altogether, 46 soluble isoforms of GFAP were separated and most of them quantified by two-dimensional immunoblotting in frontal cortices of AD patients and age-matched controls. A 60% increase in the amount of more acidic isoforms of GFAP was observed in AD and these isoforms were both phosphorylated and N-glycosylated, while more basic isoforms were O-glycosylated and exhibited no quantitative differences between post-mortem AD and control brains. These data highlight the importance of exploring isoform-specific levels of proteins in pathophysiological conditions since modifications of proteins determine their activity state, localization, turnover and interaction with other molecules. Mechanisms, structures and functional consequences of modification of GFAP isoforms remain to be clarified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Proteomic analysis of post-translational modifications
Mann, M., & Jensen, O. N. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-255 · Cited by 2,134
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,626
Molecular profile of reactive astrocytes—Implications for their role in neurologic disease
Eddleston, M., & Mucke, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90380-x · Cited by 1,431
Stryer, L. (1995) · Cited by 1,398
Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)
Eng, L. F., Ghirnikar, R. S., & Lee, Y. L. (2000) · Neurochemical Research · doi:10.1023/a:1007677003387 · Cited by 1,369
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P., Salbaum, J. M., Masters, C. L., & Beyreuther, K. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,239
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.1989.03430180093036 · Cited by 1,226 · cited 1×
“…acidic protein; Glycosylation; Immunoblotting; Oxidation; Phosphorylation; Post-mortem; Proteomics; Two-dimensional gel electrophoresis Introduction Alzheimer’s disease (AD) is the most common form of dementia resulting in a progressive loss of memory and cognitive functions (Evans et al., 1989).”
BackgroundConvergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598
Astrocyte Responses to CNS Injury
NORENBERG, M. D. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199405000-00001 · Cited by 589
Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000696 · Cited by 531
Glial cell abnormalities in major psychiatric disorders: the evidence and implications
Cotter, D. R., Pariante, C. M., & Everall, I. P. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00527-5 · Cited by 465
Post-translational modifications of tau protein in Alzheimer’s disease
Gong, C.-X., Liu, F., Grundke-Iqbal, I., & Iqbal, K. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0221-0 · Cited by 437
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
Dickson, D. W., Farlo, J., Davies, P., Crystal, H., Fuld, P. A., & Yen, S. H. (1988) · PubMed · Cited by 427
Dyrks, T., Weidemann, A., Multhaup, G., Salbaum, J. M., Lemaire, H. G., Kang, J., Müller-Hill, B., Masters, C. L., & Beyreuther, K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02900.x · Cited by 395
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS
Fabry, Z., Raine, C. S., & Hart, M. N. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90247-x · Cited by 357
Intermediate Filament Protein Partnership in Astrocytes
Eliasson, C., Sahlgren, C., Berthold, C.-H., Stakeberg, J., Celis, J. E., Betsholtz, C., Eriksson, J. E., & Pekny, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23996 · Cited by 357
Patterns of gliosis in alzheimer's disease and aging cerebrum
Beach, T. G., Walker, R., & McGeer, E. G. (1989) · Glia · doi:10.1002/glia.440020605 · Cited by 336
Si, X., Miguel-Hidalgo, J. J., O'Dwyer, G., Stockmeier, C. A., & Rajkowska, G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300525 · Cited by 268
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults
Rosengren, L. E., Wikkelsø, C., & Hagberg, L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90011-6 · Cited by 256
Biochemical and molecular studies using human autopsy brain tissue
Hynd, M. R., Lewohl, J. M., Scott, H. L., & Dodd, P. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01747.x · Cited by 236
Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease
Vehmas, A. K., Kawas, C. H., Stewart, W. F., & Troncoso, J. C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00090-8 · Cited by 230
Trojanowski, J. Q., & Lee, V. M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.15.8529836 · Cited by 216
Lefebvre, T., Ferreira, S., Dupont-Wallois, L., Bussière, T., Dupire, M.-J., Delacourte, A., Michalski, J.-C., & Caillet-Boudin, M.-L. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00477-4 · Cited by 209
Lewis, D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00393-1 · Cited by 203
Gomes, F. C. A., Paulin, D., & Moura Neto, V. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000500016 · Cited by 188
Neuroinflammatory perspectives on the two faces of Alzheimer?s disease
Eikelenboom, P., & van Gool, W. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0055-1 · Cited by 182
Webster, M. J., Knable, M. B., Johnston-Wilson, N., Nagata, K., Inagaki, M., & Yolken, R. H. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0646 · Cited by 179
Determination by PCR-RFLP of apo E genotype in a Japanese population.
Tsukamoto, K., Watanabe, T., Matsushima, T., Kinoshita, M., Kato, H., Hashimoto, Y., Kurokawa, K., & TERAMOTO, T. (1993) · PubMed · Cited by 170
Neurons, glia, and plasticity in normal brain aging
Finch, C. E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00051-4 · Cited by 170
Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease
Bigl, M., Br�ckner, M. K., Arendt, T., Bigl, V., & Eschrich, K. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050174 · Cited by 169
Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease
Liu, F., Zaidi, T., Iqbal, K., Grundke-Iqbal, I., Merkle, R. K., & Gong, C.-X. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02228-7 · Cited by 167
Hol, E. M., Roelofs, R. F., Moraal, E., Sonnemans, M. A. F., Sluijs, J. A., Proper, E. A., de Graan, P. N. E., Fischer, D. F., & van Leeuwen, F. W. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001379 · Cited by 165
Early association of reactive astrocytes with senile plaques in Alzheimer's disease
Pike, C. J., Cummings, B. J., & Cotman, C. W. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90022-5 · Cited by 164
No evidence for astrogliosis in brains of schizophrenic patients. A post‐mortem study
Falkai, P., Honer, David, Bogerts, Majtenyi, & Bayer (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00162.x · Cited by 161
Keratins Turn over by Ubiquitination in a Phosphorylation-Modulated Fashion
Ku, N.-O., & Omary, M. B. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.3.547 · Cited by 159
Glial Fibrillary Acidic Protein: Dynamic Property and Regulation by Phosphorylation
Inagaki, M., IMakamura, Y., Takeda, M., Nishimura, T., & Inagaki, N. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00839.x · Cited by 157
Nelson, W. J., & Traub, P. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.6.1146-1156.1983 · Cited by 157
Postmortem Changes in the Level of Brain Proteins
Fountoulakis, M., Hardmeier, R., Höger, H., & Lübec, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7529 · Cited by 142
Fatemi, S. H., Laurence, J. A., Araghi‐Niknam, M., Stary, J. M., Schulz, S. C., Lee, S. S., & Gottesman, I. I. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.08.014 · Cited by 138
Liu, F., Zaidi, T., Iqbal, K., Grundke, I., & Gong, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00510-9 · Cited by 133
Proteomic analysis of protein oxidation in Alzheimer's disease brain.
Korolainen, M. A., Goldsteins, G., Alafuzoff, I. I., Koıstınaho, J., & Pirttilä, T. (2002) · Electrophoresis · doi:10.1002/1522-2683(200210)23:19<3428::aid-elps3428>3.0.co;2-5 · Cited by 129
Self-citationPorchet, R., Probst, A., Bouras, C., Dráberová, E., Dráber, P., & Riederer, B. M. (2003) · PROTEOMICS · doi:10.1002/pmic.200300456 · Cited by 124
Low GSK-3 activity in frontal cortex of schizophrenic patients
Kozlovsky, N., Belmaker, R. H., & Agam, G. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00174-2 · Cited by 122
New roles for astrocytes: The nightlife of an ‘astrocyte’. La vida loca!
Horner, P. J., & Palmer, T. D. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.09.010 · Cited by 121
Post-mortem Interval Effects on the Phosphorylation of Signaling Proteins
Li, J., Gould, T. D., Yuan, P., Manji, H. K., & Chen, G. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300112 · Cited by 113
Arnold, S. E., Franz, B. R., Trojanowski, J. Q., Moberg, P. J., & Gur, R. E. (1996) · Acta Neuropathologica · doi:10.1007/s004010050425 · Cited by 112
Fukuyama, R., Izumoto, T., & Fushiki, S. (2001) · European Neurology · doi:10.1159/000050753 · Cited by 104
Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain
Korolainen, M. A., Goldsteins, G., Nyman, T. A., Alafuzoff, I. I., Koıstınaho, J., & Pirttilä, T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.11.010 · Cited by 102
Self-citationA sensitive ELISA for glial fibrillary acidic protein: application in CSF of children
Rosengren, L., Ahlsén, G., Belfrage, M., Gillberg, C., Haglid, K. G., & Hamberger, A. (1992) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(92)90004-w · Cited by 98
Glycosylation changes in Alzheimer’s disease as revealed by a proteomic approach
Kanninen, K. M., Goldsteins, G., Auriola, S. O. K., Alafuzoff, I. I., & Koıstınaho, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.013 · Cited by 97
Self-citationNoppe, M., Crols, R., Andries, D., & Löwenthal, A. (1986) · Clinica Chimica Acta · doi:10.1016/0009-8981(86)90275-5 · Cited by 96
Kussmann, M., Laessing, U., Stürmer, C. A. O., Przybylski, M., & Roepstorff, P. (1997) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199705)32:5<483::aid-jms502>3.0.co;2-j · Cited by 96
Nyman, T. A., Matikainen, S., Sareneva, T., Julkunen, I., & Kalkkinen, N. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01433.x · Cited by 95
Self-citationNielsen, A. L., Holm, I. E., Johansen, M., Bonven, B., Jørgensen, P., & Jørgensen, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112121200 · Cited by 92
Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen Sr., P., & Alafuzoff, I. (1999) · Acta Neuropathologica · doi:10.1007/s004010051002 · Cited by 91
Self-citationDamadzic, R., Bigelow, L. B., Krimer, L. S., Goldenson, D. A., Saunders, R. C., Kleinman, J. E., & Herman, M. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00529-9 · Cited by 91
Astrocytes and the plaques of Alzheimer's disease
Mandybur, T. I., & Chuirazzi, C. C. (1990) · Neurology · doi:10.1212/wnl.40.4.635 · Cited by 89
MURAMORI, F., KOBAYASHI, K., & NAKAMURA, I. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1998.tb02706.x · Cited by 85
Emamian, E. S., Karayiorgou, M., & Gogos, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4650-03.2004 · Cited by 80
Changes in CREB-phosphorylation during recovery from major depression
Koch, J. M., Kell, S., Hinze‐Selch, D., & Aldenhoff, J. B. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00056-0 · Cited by 79
Protein Phosphorylation and APP Metabolism
Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2003) · Neurochemical Research · doi:10.1023/a:1025630627319 · Cited by 76
Astrogliosis and the ApoE Genotype
Overmyer, M., Helisalmi, S., Soininen, H. S., Laakso, M., Riekkinen, P., & Alafuzoff, I. I. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017128 · Cited by 73
Self-citationProtective Role of Phosphorylation in Turnover of Glial Fibrillary Acidic Protein in Mice
Takemura, M., Gomi, H., Colucci‐Guyon, E., & Itohara, S. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06972.2002 · Cited by 71
Papasozomenos, S. C. (1989) · PubMed · Cited by 70
Postmortem changes in the phosphorylation state of tau-protein in the rat brain
Gärtner, U., Janke, C., Holzer, M., Vanmechelen, E., & Arendt, T. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00094-3 · Cited by 69
Li, X., Friedman, A. B., Roh, M., & Jope, R. S. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02898.x · Cited by 64
Astrocytes: a cellular player in Aβ clearance and degradation
Guénette, S. Y. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00112-6 · Cited by 64
Glial Fibrillary Acidic Protein is Greatly Modified by Oxidative Stress in Aceruloplasminemia Brain
Kaneko, K., Nakamura, A., Yoshida, K., Kametani, F., Higuchi, K., & Ikeda, S. (2002) · Free Radical Research · doi:10.1080/10715760290019327 · Cited by 63
Hilbig, H., Bidmon, H. J., Oppermann, O. T., & Remmerbach, T. W. (2004) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2004.08.002 · Cited by 55
Altered Glycosylation Pattern of Proteins in Alzheimer Disease
Guevara, J., Espinosa, B., Zenteno, E., Vázquez, L., Luna, J., Perry, G. L., & Mena, R. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199810000-00003 · Cited by 55
Alafuzoff, I. I., Helisalmi, S., Arto, M., Paavo, R., & Hilkka, S. (1999) · Stroke · doi:10.1161/01.str.30.3.613 · Cited by 52
Self-citationA new role for astrocytes: β-amyloid homeostasis and degradation
Nicoll, J. A. R., & Weller, R. O. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00109-6 · Cited by 51
Fodero, L. R., Sáez‐Valero, J., McLean, C., Martins, R. N., Beyreuther, K. T., Masters, C. L., Robertson, T. A., & Small, D. H. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00902.x · Cited by 48
Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease
Ross, G. W., O'Callaghan, J. P., Sharp, D. S., Petrovitch, H., Miller, D. B., Abbott, R. D., Nelson, J., Launer, L. J., Foley, D., Burchfiel, C. M., et al. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.02098.x · Cited by 42
Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons
Burack, M. A., & Halpain, S. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00546-3 · Cited by 38
Distribution of phosphorylated glial fibrillary acidic protein in the mouse central nervous system
Takemura, M., Nishiyama, H., & Itohara, S. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00513.x · Cited by 37
Phosphorylation of the glial fibrillary acidic protein
Noetzel, M. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270208 · Cited by 36
Tsuji, T., Shimohama, S., Kamiya, S., Sazuka, T., & Ohara, O. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00120-3 · Cited by 35
Conway, R. G., & Routtenberg, A. (1979) · Brain Research · doi:10.1016/0006-8993(79)90109-4 · Cited by 34
Valentim, L. M., Michalowski, C. B., Gottardo, S. P., Pedroso, L. S., Gestrich, L. G., Netto, C. A., Salbego, C. G., & Rodnight, R. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00707-6 · Cited by 34
Hanzel, D. K., Trojanowski, J. Q., Johnston, R. F., & Loring, J. F. (1999) · Nature Biotechnology · doi:10.1038/5225 · Cited by 33
Comings, D. E. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.4.805 · Cited by 33
Ciesielski-Treska, J., Goetschy, J., & Aunis, D. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb07939.x · Cited by 31
O-Glycosylation in Sprouting Neurons in Alzheimer Disease, Indicating Reactive plasticity
Espinosa, B., Zenteno‐Cuevas, R., Mena, R., Robitaille, Y., Zenteno, E., & Guevara, J. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.5.441 · Cited by 27
Cross, A. J., Crow, T. J., Dawson, J. M., Ferrier, I. N., Johnson, J. A., Peters, T. J., & Reynolds, G. P. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00693.x · Cited by 25
An unconventional hypothesis of oxidation in alzheimer's disease: intersections with excitotoxicity
Barger, S. W. (2004) · Frontiers in bioscience · doi:10.2741/1481 · Cited by 22
Pitfalls in the quantitative estimation of β-amyloid immunoreactivity in human brain tissue
Kraszpulski, M., Soininen, H. S., Riekkinen, P. J., & Alafuzoff, I. I. (1998) · Histochemistry and Cell Biology · doi:10.1007/s004180050305 · Cited by 17
Self-citationCharacterization of an O-Glycosylated Plaque-Associated Protein from Alzheimer Disease Brain
Espinosa, B., Guevara, J., Cruz, P. A. H., Slomianny, M., Guzmán, A., Martínez-Cairo, S., & Zenteno, E. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.34 · Cited by 17
Low Initial Tau Phosphorylation in Human Brain Biopsy Samples
Song, J., Combs, C. K., Pilcher, W. H., Song, L., Utal, A. K., & Coleman, P. D. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00043-2 · Cited by 16
Wu, K. H. C., Penfold, P. L., & Billson, F. A. (2002) · Clinical and Experimental Ophthalmology · doi:10.1046/j.1442-9071.2002.00515.x · Cited by 10
Routtenberg, A., Morgan, D., Conway, R. G., Schmidt, J. M., & Ghetti, B. F. (1981) · Brain Research · doi:10.1016/0006-8993(81)91036-2 · Cited by 9
Greber (1999) · doi:10.1002/(sici)1522-2683(19990101)20:4/5<928::aid-elps928>3.0.co;2-z
Cited by
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
Moloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764
Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
Proteomic and oxidative stress analysis in human brain samples of Huntington disease
Sorolla, M. A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J., & Cabiscol, E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.014 · Cited by 301
Venkateshappa, C., Harish, G., Mahadevan, A., Srinivas Bharath, M. M., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0755-8 · Cited by 232
Metadata
- Authors
- Korolainen, M. A., Auriola, S., Nyman, T. A., Alafuzoff, I., & Pirttilä, T.
- Affiliations
- University of Eastern Finland (FI)
- Åbo Akademi University (FI)
- Corresponding author
- Korolainen, Minna A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 20
- Issue
- 3
- Pages
- 858-870
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2008337653
- Cited by
- 133
- References
- 104
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 9 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 12 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- doaj.org
- Licence
- cc-by-sa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- glial fibrillary acidic protein, Alzheimer's disease, protein phosphorylation, N-glycosylation, O-glycosylation, astrocytes, chronic inflammation, brain aging, frontal cortex, postmortem brain, protein modification
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Astrocytes, Brain, Encephalitis, Female, Glial Fibrillary Acidic Protein, Gliosis, Glycosylation, Humans, Male, Middle Aged, Phosphorylation, Protein Isoforms, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.